ISDA

Entry Detail

PDB ID:

5D7R

Keywords:

ISOMERASE/ISOMERASE INHIBITOR

Title:

Crystal structure of the ATP binding domain of S. aureus GyrB complexed with a ligand

Biological Source:

Source Organism:

Staphylococcus aureus

Host Organism:

Escherichia coli

PDB Version:

Deposition Date:

2015-08-14

Release Date:

2015-11-18

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

1.55 Å

R-Value Free:

0.21

R-Value Work:

0.18

R-Value Observed:

0.18

Space Group:

C 1 2 1

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Description:DNA gyrase subunit B
Chain IDs:A, B
Chain Length:212
Number of Molecules:2
Biological Source:Staphylococcus aureus

UniProt ID:P0A0K8 Pfam ID:PF02518 EC:5.6.2.2

Ligand Molecules

57Y

MPD

Primary Citation

Discovery of Indazole Derivatives as a Novel Class of Bacterial Gyrase B Inhibitors.

Zhang, J, Yang, Q, Romero, J.A, Cross, J, Wang, B, Poutsiaka, K.M, Epie, F, Bevan, D, Wu, Y, Moy, T, Daniel, A, Chamberlain, B, Carter, N, Shotwell, J, Arya, A, Kumar, V, Silverman, J, Nguyen, K, Metcalf, C.A, Ryan, D, Lippa, B, Dolle, R.E.Show

Acs Med.Chem.Lett. 6 1080 1085 (2015)

PMID: 26487916 DOI: 10.1021/acsmedchemlett.5b00266

Abstact

Antibacterials with a novel mechanism of action offer a great opportunity to combat widespread antimicrobial resistance. Bacterial DNA Gyrase is a clinically validated target. Through physiochemical property optimization of a pyrazolopyridone hit, a novel class of GyrB inhibitors were discovered. Guided by structure-based drug design, indazole derivatives with excellent enzymatic and antibacterial activity as well as great animal efficacy were discovered.

Legend

Protein

Chemical

Disease

Primary Citation of related structures